Document is current
Any future updates will be listed below
-
Authors
Everett, Jeremy R. https://orcid.org/0000-0003-1550-4482
Karpe, Fredrik https://orcid.org/0000-0002-2751-1770
Le Guennec, Adrien
Neville, Matt
Redfield, Christina
-
Funding
Funding for this research was provided by:
National Institute for Health Research (NIHR) Oxford Biomedical Research Centre
Wellcome Trust (202767/Z/16/Z)
British Heart Foundation (IG/16/2/32273)
Engineering and Physical Sciences Research Council (EP/R029849/1)
University of Oxford Wellcome Institutional Strategic Support Fund
Edward Penley Abraham Cephalosporin Fund
- License Information
-
More Information
Article History
Received: 16 January 2025
Accepted: 1 July 2025
First Online: 9 September 2025
Declarations
:
: Jeremy Everett is a co-inventor on a patent application relating to the use of 2,3-butanediol (Everett et al., ). The Oxford BioBank is funded by the NIHR Oxford Biomedical Research Centre (BRC). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social care.
